$INBP
INTEGRATED BIOPHARMA INC

2018 Form 10-K Financial Statement

#000143774918016922 Filed on September 12, 2018

View on sec.gov

Income Statement

Concept 2018 2017 Q2 2017
Revenue $43.71M $11.25M $46.95M
YoY Change -6.91% -1.14% 11.23%
Cost Of Revenue $38.72M $9.540M $40.29M
YoY Change -3.88% 0.53% 9.74%
Gross Profit $4.988M $1.710M $6.667M
YoY Change -25.18% -9.52% 21.13%
Gross Profit Margin 11.41% 15.2% 14.2%
Selling, General & Admin $3.294M $880.0K $3.480M
YoY Change -5.34% 0.0% 2.65%
% of Gross Profit 66.04% 51.46% 52.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $348.0K $90.00K $393.0K
YoY Change -11.45% 0.0% 11.97%
% of Gross Profit 6.98% 5.26% 5.89%
Operating Expenses $3.294M $870.0K $3.480M
YoY Change -5.34% -1.14% 2.65%
Operating Profit $1.694M $840.0K $3.187M
YoY Change -46.85% -16.83% 50.76%
Interest Expense $926.0K -$20.00K $911.0K
YoY Change 1.65% -87.5% -4.41%
% of Operating Profit 54.66% -2.38% 28.58%
Other Income/Expense, Net -$689.0K $0.00 -$1.331M
YoY Change -48.23% -100.0% 43.89%
Pretax Income $1.005M $780.0K $1.856M
YoY Change -45.85% -11.36% 56.1%
Income Tax $326.0K -$760.0K -$490.0K
% Of Pretax Income 32.44% -97.44% -26.4%
Net Earnings $679.0K $1.540M $2.346M
YoY Change -71.06% 105.33% 144.89%
Net Earnings / Revenue 1.55% 13.69% 5.0%
Basic Earnings Per Share $0.03 $0.11
Diluted Earnings Per Share $0.02 $28.11K $0.10
COMMON SHARES
Basic Shares Outstanding 21.14M 21.12M
Diluted Shares Outstanding 30.32M 30.17M

Balance Sheet

Concept 2018 2017 Q2 2017
SHORT-TERM ASSETS
Cash & Short-Term Investments $228.0K $600.0K $597.0K
YoY Change -61.81% -33.33% -33.37%
Cash & Equivalents $132.0K
Short-Term Investments $470.0K $465.0K
Other Short-Term Assets $493.0K $754.0K $289.0K
YoY Change 70.59% 206.5% 17.48%
Inventory $7.741M $7.645M $7.645M
Prepaid Expenses
Receivables $3.796M $4.020M $4.020M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.26M $12.55M $12.55M
YoY Change -2.33% 4.3% 4.3%
LONG-TERM ASSETS
Property, Plant & Equipment $1.651M $1.601M $1.601M
YoY Change 3.12% 2.17% 2.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $659.0K $1.040M $1.044M
YoY Change -36.88% 197.14% 199.14%
Total Long-Term Assets $2.310M $2.645M $2.645M
YoY Change -12.67% 38.05% 38.05%
TOTAL ASSETS
Total Short-Term Assets $12.26M $12.55M $12.55M
Total Long-Term Assets $2.310M $2.645M $2.645M
Total Assets $14.57M $15.20M $15.20M
YoY Change -4.13% 8.94% 8.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.184M $4.177M $4.177M
YoY Change 0.17% -23.62% -23.62%
Accrued Expenses $1.060M $1.180M $1.184M
YoY Change -10.47% -2.48% -2.23%
Deferred Revenue
YoY Change
Short-Term Debt $4.894M $4.680M $4.676M
YoY Change 4.66% 11.16% 11.07%
Long-Term Debt Due $6.042M $1.118M $1.118M
YoY Change 440.43% 24.64% 24.64%
Total Short-Term Liabilities $16.18M $11.16M $11.16M
YoY Change 45.05% -5.36% -5.36%
LONG-TERM LIABILITIES
Long-Term Debt $3.624M $4.246M $9.467M
YoY Change -61.72% -18.98% -9.08%
Other Long-Term Liabilities $0.00 $500.0K $503.0K
YoY Change -100.0% 525.0% 561.84%
Total Long-Term Liabilities $3.624M $4.246M $9.970M
YoY Change -63.65% -18.98% -4.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.18M $11.16M $11.16M
Total Long-Term Liabilities $3.624M $4.246M $9.970M
Total Liabilities $19.80M $21.13M $21.13M
YoY Change -6.25% -5.17% -5.17%
SHAREHOLDERS EQUITY
Retained Earnings -$50.63M
YoY Change -4.43%
Common Stock $42.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $99.00K
YoY Change 0.0%
Treasury Stock Shares $34.90K
Shareholders Equity -$5.236M -$5.929M -$5.929M
YoY Change
Total Liabilities & Shareholders Equity $14.57M $15.20M $15.20M
YoY Change -4.13% 8.94% 8.94%

Cashflow Statement

Concept 2018 2017 Q2 2017
OPERATING ACTIVITIES
Net Income $679.0K $1.540M $2.346M
YoY Change -71.06% 105.33% 144.89%
Depreciation, Depletion And Amortization $348.0K $90.00K $393.0K
YoY Change -11.45% 0.0% 11.97%
Cash From Operating Activities $1.168M -$820.0K $397.0K
YoY Change 194.21% -456.52% -166.84%
INVESTING ACTIVITIES
Capital Expenditures $247.0K -$20.00K $327.0K
YoY Change -24.46% -71.43% 200.0%
Acquisitions
YoY Change
Other Investing Activities $5.000K $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$242.0K -$20.00K -$327.0K
YoY Change -25.99% -71.43% 205.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -830.0K 770.0K -333.0K
YoY Change 149.25% -485.0% -132.49%
NET CHANGE
Cash From Operating Activities 1.168M -820.0K 397.0K
Cash From Investing Activities -242.0K -20.00K -327.0K
Cash From Financing Activities -830.0K 770.0K -333.0K
Net Change In Cash 96.00K -70.00K -263.0K
YoY Change -136.5% 75.0% -128.65%
FREE CASH FLOW
Cash From Operating Activities $1.168M -$820.0K $397.0K
Capital Expenditures $247.0K -$20.00K $327.0K
Free Cash Flow $921.0K -$800.0K $70.00K
YoY Change 1215.71% -366.67% -109.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Document Type
DocumentType
10-K
CY2018 inbp Accretion On Convertible Debt Net Of Tax
AccretionOnConvertibleDebtNetOfTax
39000
CY2017 inbp Accretion On Convertible Debt Net Of Tax
AccretionOnConvertibleDebtNetOfTax
39000
CY2018 inbp Accretion On Embedded Derivative Feature
AccretionOnEmbeddedDerivativeFeature
39000
CY2017 inbp Accretion On Embedded Derivative Feature
AccretionOnEmbeddedDerivativeFeature
39000
CY2018 inbp Amortization Of Prepaid Convertible Debt Financing Costs Net Of Taxes
AmortizationOfPrepaidConvertibleDebtFinancingCostsNetOfTaxes
6000
CY2017 inbp Amortization Of Prepaid Convertible Debt Financing Costs Net Of Taxes
AmortizationOfPrepaidConvertibleDebtFinancingCostsNetOfTaxes
6000
CY2018 inbp Effective Income Tax Rate Reconciliation Statutory Minimum Taxes Percent
EffectiveIncomeTaxRateReconciliationStatutoryMinimumTaxesPercent
0.098
CY2017 inbp Effective Income Tax Rate Reconciliation Statutory Minimum Taxes Percent
EffectiveIncomeTaxRateReconciliationStatutoryMinimumTaxesPercent
0.1
CY2018 inbp Gain From Assets Contribution To Investment
GainFromAssetsContributionToInvestment
88000
CY2017 inbp Gain From Assets Contribution To Investment
GainFromAssetsContributionToInvestment
CY2018Q2 inbp Operating Leases Future Minimum Payments Due After Sixth Year
OperatingLeasesFutureMinimumPaymentsDueAfterSixthYear
1392000
CY2018Q2 inbp Operating Leases Future Minimum Payments Due In Sixyears
OperatingLeasesFutureMinimumPaymentsDueInSixyears
563000
CY2018Q2 inbp Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Originally Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOriginallyAuthorized
7000000
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4184000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4177000
CY2018Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
141000
CY2017Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
77000
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017Q4 dei Entity Public Float
EntityPublicFloat
1642853
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
44759000
CY2017 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
49000
CY2018 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
14000
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3796000
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4020000
CY2018 us-gaap Accretion Expense
AccretionExpense
105000
CY2017 us-gaap Accretion Expense
AccretionExpense
105000
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6790000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6705000
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
44773000
CY2018Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1060000
CY2017Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1184000
CY2018 us-gaap Advertising Cost Policy Expensed Advertising Cost
AdvertisingCostPolicyExpensedAdvertisingCost
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Trade Marketing and Merchandising.</div></div> In order to support the Company&#x2019;s proprietary nutraceutical product lines, various promotional activities are conducted through the retail trade, distributors or directly with consumers, including in-store display and product placement programs, feature price discounts, coupons, and other similar activities. The Company regularly reviews and revises, when it deems necessary, estimates of costs to the Company for these promotional programs based on estimates of what will be redeemed by the retail trade, distributors, or consumers. These estimates are made using various techniques, including historical data on performance of similar promotional programs. Differences between estimated expense and actual performance are generally <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> material and are recognized as a change in management&#x2019;s estimate in a subsequent period.
CY2018 us-gaap Advertising Expense
AdvertisingExpense
17000
CY2017 us-gaap Advertising Expense
AdvertisingExpense
22000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49000
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
134000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
99000
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
39000
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
39000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
150000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
313100
CY2018Q2 us-gaap Assets
Assets
14568000
CY2017Q2 us-gaap Assets
Assets
15196000
CY2018Q2 us-gaap Assets Current
AssetsCurrent
12154000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
12551000
CY2018Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
269000
CY2017Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
307000
CY2018 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
53000
CY2017 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
395000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
228000
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
96000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-263000
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.002
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.002
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21170074
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21135174
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21170074
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21135174
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
42000
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
42000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
38722000
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
40287000
CY2018 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
358000
CY2017 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
36000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
30000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
170000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
306000
CY2016Q1 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
41000
CY2018Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0519
CY2017Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0486
CY2018 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
430000
CY2017 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
495000
CY2018Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
45000
CY2017Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
75000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
152000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-823000
CY2018Q2 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
21000
CY2017Q2 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
31000
CY2018Q2 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
3000
CY2017Q2 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
201000
CY2018Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
105000
CY2017Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
139000
CY2018Q2 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
512000
CY2017Q2 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
707000
CY2018Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
671000
CY2017Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
823000
CY2018Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
671000
CY2017Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
823000
CY2018Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8247000
CY2017Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
13314000
CY2018Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
143000
CY2017Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
94000
CY2018Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8137000
CY2017Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13394000
CY2018Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
223000
CY2017Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
269000
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
67000
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
62000
CY2018Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
92000
CY2017Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
221000
CY2018 us-gaap Depreciation
Depreciation
239000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
51100
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
160600
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
271667
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
118333
CY2017 us-gaap Depreciation
Depreciation
292000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
348000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
393000
CY2018 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
494000
CY2017 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-427000
CY2018Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
CY2017Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
503000
CY2018 us-gaap Dilutive Securities
DilutiveSecurities
-494000
CY2017 us-gaap Dilutive Securities
DilutiveSecurities
427000
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.324
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.26
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.275
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.329
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.79
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.2
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.01
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.03
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.07
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.06
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5000
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2018 us-gaap Gross Profit
GrossProfit
4988000
CY2017 us-gaap Gross Profit
GrossProfit
6667000
CY2017 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2018 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1005000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1856000
CY2018Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2017Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
326000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-490000
CY2018 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
202000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
221000
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
366000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1292000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-182000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
884000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
200000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2870950
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11155000
CY2018Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2017Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2018Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4894000
CY2017Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4676000
CY2018 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-494000
CY2017 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
427000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
96000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-111000
CY2018 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-133000
CY2017 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-27000
CY2018 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-97000
CY2017 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
43000
CY2018 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
8230769
CY2017 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
8230769
CY2018 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
951399
CY2017 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
825893
CY2018 us-gaap Interest Expense
InterestExpense
926000
CY2017 us-gaap Interest Expense
InterestExpense
911000
CY2018 us-gaap Interest Expense Lessee Assets Under Capital Lease
InterestExpenseLesseeAssetsUnderCapitalLease
25000
CY2017 us-gaap Interest Expense Lessee Assets Under Capital Lease
InterestExpenseLesseeAssetsUnderCapitalLease
25000
CY2018 us-gaap Interest Expense Other
InterestExpenseOther
27000
CY2017 us-gaap Interest Expense Other
InterestExpenseOther
23000
CY2018 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
66000
CY2017 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
66000
CY2018 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
216000
CY2017 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
195000
CY2012Q2 us-gaap Interest Paid
InterestPaid
333000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
800000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
884000
CY2018Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
69000
CY2017Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
57000
CY2018Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1355000
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1835000
CY2018Q2 us-gaap Inventory Net
InventoryNet
7741000
CY2017Q2 us-gaap Inventory Net
InventoryNet
7645000
CY2018Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4179000
CY2017Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3847000
CY2018Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2207000
CY2017Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1963000
CY2018Q2 us-gaap Liabilities
Liabilities
19804000
CY2017Q2 us-gaap Liabilities
Liabilities
21125000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14568000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15196000
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
16180000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2718183
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2439250
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.40
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.29
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.11
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.09
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2018Q2 us-gaap Long Term Debt
LongTermDebt
9336000
CY2017Q2 us-gaap Long Term Debt
LongTermDebt
10115000
CY2018Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
773000
CY2017Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1118000
CY2018Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3624000
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4246000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-830000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-333000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-242000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-327000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1168000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
397000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
679000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
2346000
CY2018 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
446000
CY2017 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
3013000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-689000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1331000
CY2018Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
5269000
CY2017Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
CY2018Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
CY2017Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
5221000
CY2018 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
1694000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
3187000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4302000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
571000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
584000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
585000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
607000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1005000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
967000
CY2018Q2 us-gaap Other Assets Current
OtherAssetsCurrent
389000
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
754000
CY2012Q2 us-gaap Other Expenses
OtherExpenses
217000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
101000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43000
CY2018 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1000
CY2017 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
CY2018 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
300000
CY2017 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
327000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
247000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
327000
CY2018 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 0pt 0pt 18pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Reclassifications</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">. </div></div>Certain prior year amounts have been reclassified to conform to the current year presentation.</div></div></div>
CY2018 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
41164000
CY2017 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
45385000
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6000
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000
CY2018 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
147000
CY2017 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
28000
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8441000
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8306000
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1651000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1601000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
42000
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1000
CY2018 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
40945000
CY2017 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
44919000
CY2018 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
233000
CY2017 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
131000
CY2018 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
959000
CY2017 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
829000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49952000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-50631000
CY2018 us-gaap Revenues
Revenues
43710000
CY2017 us-gaap Revenues
Revenues
46954000
CY2018 us-gaap Sale Leaseback Transaction Net Proceeds Financing Activities
SaleLeasebackTransactionNetProceedsFinancingActivities
143000
CY2017 us-gaap Sale Leaseback Transaction Net Proceeds Financing Activities
SaleLeasebackTransactionNetProceedsFinancingActivities
158000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
14000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
49000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3294000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3480000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
6000000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
13000000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4620419
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2506683
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2439250
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.30
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.11
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.82
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.06
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.24
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.15
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.24
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.09
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
0.25
CY2018Q2 us-gaap Share Price
SharePrice
0.15
CY2017Q2 us-gaap Share Price
SharePrice
0.19
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
180000
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
194000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y219D
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
30000
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-5236000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-5929000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
-8327000
CY2018 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
202000
CY2018Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
34900
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
34900
CY2018Q2 us-gaap Treasury Stock Value
TreasuryStockValue
99000
CY2017Q2 us-gaap Treasury Stock Value
TreasuryStockValue
99000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 0pt 0pt 18pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates.</div></div> The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> readily apparent from other sources. The most significant estimates include:</div> <div style=" margin: 0pt 0pt 0pt 18pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 18pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#x25cf;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sales returns and allowances;</div> <div style=" margin: 0pt 0pt 0pt 18pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#x25cf;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;trade marketing and merchandising;</div> <div style=" margin: 0pt 0pt 0pt 18pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#x25cf;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;allowance for doubtful accounts;</div> <div style=" margin: 0pt 0pt 0pt 18pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#x25cf;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;inventory valuation;</div> <div style=" margin: 0pt 0pt 0pt 18pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#x25cf; &nbsp; &nbsp; valuation and recoverability of long-lived and intangible assets;</div> <div style=" margin: 0pt 0pt 0pt 18pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#x25cf;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;income taxes and valuation allowance on deferred income taxes, and;</div> <div style=" margin: 0pt 0pt 0pt 18pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#x25cf;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;accruals for, and the probability of, the outcome of any current litigation.</div> <div style=" margin: 0pt 0pt 0pt 18pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 0pt 0pt 18pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">On a continual basis, management reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</div></div></div>
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-278000
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1321000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30317342
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30173740
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21135174
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21117078

Files In Submission

Name View Source Status
0001437749-18-016922-index-headers.html Edgar Link pending
0001437749-18-016922-index.html Edgar Link pending
0001437749-18-016922.txt Edgar Link pending
0001437749-18-016922-xbrl.zip Edgar Link pending
ex_123706.htm Edgar Link pending
ex_123707.htm Edgar Link pending
ex_123708.htm Edgar Link pending
ex_123709.htm Edgar Link pending
ex_123710.htm Edgar Link pending
ex_123711.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
inbp-20180630.xml Edgar Link completed
inbp-20180630.xsd Edgar Link pending
inbp-20180630_cal.xml Edgar Link unprocessable
inbp-20180630_def.xml Edgar Link unprocessable
inbp-20180630_lab.xml Edgar Link unprocessable
inbp-20180630_pre.xml Edgar Link unprocessable
inbp20180630_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending